Contributor list |
|
ix | |
Acknowledgements |
|
xi | |
Introduction |
|
xii | |
|
|
|
|
1 | (36) |
|
|
|
1 | (1) |
|
Defining non-medical prescribing |
|
|
2 | (1) |
|
The non-medical prescribing vision |
|
|
3 | (3) |
|
Changes in clinical practice |
|
|
6 | (2) |
|
|
8 | (1) |
|
|
9 | (1) |
|
The public health context |
|
|
10 | (1) |
|
|
11 | (1) |
|
Differentiating between prescribers |
|
|
12 | (9) |
|
Nurse non-medical prescribers |
|
|
21 | (4) |
|
Pharmacist non-medical prescribers |
|
|
25 | (1) |
|
Allied health professional non-medical prescribers |
|
|
26 | (4) |
|
Access to education programmes |
|
|
30 | (1) |
|
Summary of the context of prescribing |
|
|
31 | (2) |
|
|
33 | (4) |
|
2 Professional, Legal and Ethical Issues in Relation to Prescribing Practice |
|
|
37 | (58) |
|
|
Part 1 Professional Issues |
|
|
38 | (11) |
|
The regulatory framework for prescribing |
|
|
38 | (11) |
|
|
49 | (35) |
|
|
49 | (12) |
|
Legal aspects of autonomy and gaining consent |
|
|
61 | (5) |
|
The importance of consent |
|
|
66 | (18) |
|
|
84 | (11) |
|
|
85 | (1) |
|
|
85 | (1) |
|
|
85 | (3) |
|
Doctrine of double effect |
|
|
88 | (2) |
|
|
90 | (1) |
|
|
90 | (1) |
|
|
91 | (3) |
|
|
94 | (1) |
|
3 Factors Influencing Prescribing |
|
|
95 | (28) |
|
|
|
95 | (8) |
|
|
103 | (7) |
|
|
110 | (7) |
|
|
117 | (2) |
|
|
119 | (4) |
|
4 Effective Consultation and `the Consultation Umbrella' |
|
|
123 | (39) |
|
|
Presenting the consultation umbrella |
|
|
124 | (1) |
|
Consultation models in context |
|
|
125 | (4) |
|
The value of therapeutic communication |
|
|
129 | (8) |
|
The consultation umbrella - explained |
|
|
137 | (14) |
|
|
151 | (7) |
|
|
158 | (1) |
|
|
159 | (3) |
|
5 Essential Pharmacology, Therapeutics and Medicines Management for Non-medical Prescribers |
|
|
162 | (36) |
|
|
|
|
|
|
|
Pharmacology as part of prescribing practice |
|
|
163 | (1) |
|
Brief introduction to pharmacological terms |
|
|
164 | (11) |
|
Guide through processes to build and develop one's own formulary, with examples |
|
|
175 | (5) |
|
BNF Practise using this essential resource |
|
|
180 | (1) |
|
Prescribing in co-morbidity |
|
|
181 | (2) |
|
Management and avoidance of drug interactions |
|
|
183 | (2) |
|
Management and avoidance of adverse medicine reactions |
|
|
185 | (5) |
|
Drugs with a narrow therapeutic index or range |
|
|
190 | (3) |
|
|
193 | (1) |
|
Other resources to support your learning |
|
|
194 | (1) |
|
|
195 | (3) |
|
6 The Multidisciplinary Prescribing Team |
|
|
198 | (24) |
|
|
Defining `the multidisciplinary prescribing team' |
|
|
198 | (2) |
|
The benefits to prescribing |
|
|
200 | (4) |
|
|
204 | (6) |
|
Non-medical prescribing lead |
|
|
210 | (1) |
|
The multidisciplinary non-medical prescribing team |
|
|
211 | (3) |
|
Commissioning and the MDPT |
|
|
214 | (2) |
|
|
216 | (1) |
|
|
217 | (2) |
|
|
219 | (3) |
|
|
222 | (39) |
|
|
|
|
223 | (1) |
|
|
223 | (2) |
|
|
225 | (2) |
|
|
227 | (2) |
|
|
229 | (1) |
|
|
230 | (2) |
|
|
232 | (2) |
|
|
234 | (2) |
|
Examination of body systems |
|
|
236 | (18) |
|
|
254 | (3) |
|
|
257 | (2) |
|
|
259 | (2) |
|
8 Prescribing for Specific Groups |
|
|
261 | (37) |
|
|
|
Prescribing in liver disease |
|
|
261 | (6) |
|
Prescribing in renal disease |
|
|
267 | (5) |
|
|
272 | (7) |
|
Prescribing for older people |
|
|
279 | (4) |
|
Prescribing for children and young people |
|
|
283 | (8) |
|
|
291 | (4) |
|
|
295 | (3) |
|
9 Enhancing Non-medical Prescribing |
|
|
298 | (29) |
|
|
|
Current practice in prescribing |
|
|
298 | (1) |
|
UK history of prescribing |
|
|
299 | (3) |
|
Non-medical prescribing in other countries |
|
|
302 | (1) |
|
The impact of prescribing |
|
|
302 | (3) |
|
Issues emerging from the introduction of non-medical prescribing |
|
|
305 | (15) |
|
|
320 | (1) |
|
|
321 | (1) |
|
|
322 | (5) |
|
|
327 | (5) |
|
|
327 | (1) |
|
|
328 | (1) |
|
|
328 | (1) |
|
|
329 | (1) |
|
|
329 | (1) |
|
|
329 | (1) |
|
|
330 | (1) |
|
|
330 | (1) |
|
Case study 9 Callum (with CMP) |
|
|
330 | (2) |
|
Health Professional Case Studies |
|
|
332 | (5) |
|
|
332 | (1) |
|
|
333 | (1) |
|
|
333 | (1) |
|
|
334 | (1) |
|
|
334 | (1) |
|
|
335 | (1) |
|
|
335 | (1) |
|
|
336 | (1) |
|
|
336 | (1) |
|
Case study J Simon and Janice |
|
|
336 | (1) |
Index |
|
337 | |